Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07042321

Risk Factors for Microvascular Obstruction Post-Emergency PCI in AMI Patients

Triglyceride Glucol Index for Predicting the Value of No-Reflow in Patients Undergoing Emergency PCI for Acute Myocardial Infarction

Status
Recruiting
Phase
Study type
Observational
Enrollment
300 (estimated)
Sponsor
The Third Xiangya Hospital of Central South University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The goal of this prospective cohort study is to investigate the relationship between the TyG index and early identification of MVO in AMI patients undergoing emergency PCI and CMR imaging. The study will enroll approximately 300 AMI patients treated at Xiangya Third Hospital of Central South University from June 2024 to August 2025. The main questions it aims to answer are: * How does the TyG index correlate with the early detection of MVO? * What differences in cardiovascular adverse events during hospitalization exist between groups with varying TyG index levels? Participants will undergo emergency PCI and CMR imaging within 3-7 days post-procedure. Data collected will include demographic characteristics, clinical history, coronary angiography data, laboratory test indicators (especially metabolic markers such as blood glucose and lipids), IVUS-related plaque information, and CMR results.

Conditions

Timeline

Start date
2024-06-01
Primary completion
2025-08-31
Completion
2025-08-31
First posted
2025-06-29
Last updated
2025-07-02

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT07042321. Inclusion in this directory is not an endorsement.